Endpoints for mouse abdominal tumor models: refinement of current criteria.
about
Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene.Use of a body condition score technique to assess health status in a rat model of polycystic kidney disease.Identification of markers for imminent death in mice used in longevity and aging researchConventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraftValidation of a body condition scoring system in rhesus macaques (Macaca mulatta): inter- and intrarater variability.Markers for heightened monitoring, imminent death, and euthanasia in aged inbred miceIL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasmsHealth Evaluation of Experimental Laboratory MicePractical pathology of aging mice.Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model.Progression of ulcerative dermatitis lesions in C57BL/6Crl mice and the development of a scoring system for dermatitis lesionsDepletion of mucin in mucin-producing human gastrointestinal carcinoma: Results from in vitro and in vivo studies with bromelain and N-acetylcysteinePasireotide Therapy of Multiple Endocrine Neoplasia Type 1-Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression.Weight loss and reduced body temperature determine humane endpoints in a mouse model of ocular herpesvirus infectionPredictive observation-based endpoint criteria for mice receiving total body irradiationAgonists of the TRAIL Death Receptor DR5 Sensitize Intestinal Stem Cells to Chemotherapy-Induced Cell Death and Trigger Gastrointestinal ToxicityUsing body temperature, food and water consumption as biomarkers of disease progression in mice with Eμ-myc lymphoma.Endpoint refinement for total body irradiation of C57BL/6 mice.Long-term effectiveness of irreversible electroporation in a murine model of colorectal liver metastasis.Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR.IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis
P2860
Q33713310-0629D826-3B11-4FA1-95B0-6F620B6F3379Q33755133-DC0FEF9B-A60C-4337-8B98-E596A9E083D3Q33880081-AA3A2B6C-D9FB-441A-A678-B15D8A0E314FQ35592388-CCC811A4-FB98-4976-9A04-34B3CF8B471AQ35749230-1AD2CCD8-B3FC-4C26-98D3-3DF5BA20F0E4Q36000010-495532DF-1E52-4699-B487-347099E77E16Q36040193-E29A021F-1601-4F53-BBD7-B8D3498D43A1Q36102497-994D7465-DFA1-4058-AE34-D0922CDCFDEEQ36159848-6061476B-269F-4B6E-85FC-B9ABF79E2FFBQ36205238-AC96A20D-E604-46D8-8A1A-A0FE65F1E9CFQ36248637-35923DDC-7790-417E-8C26-03B79A5BF4B6Q36545154-79BE3B0C-CA62-4E7F-B42D-8A9D46ACD2E1Q36911589-62E0CA38-C995-4227-A374-4DE7152FB752Q36949116-02BBBDE8-A418-4EFE-8F8E-14A5AE6ABBDEQ37113805-4F28282D-5ECF-4792-AA55-787F8C57AA7BQ37211515-7DE6069C-348D-469A-9014-D2DC7A451A50Q37594415-E4FB7CFE-D42E-4049-96A1-754E9FC3AFAAQ42154414-DB2D20EA-429E-45EF-8F8A-FC5EC5E0220CQ42314843-05F45C06-BC4C-4BF1-A284-844A676C7E02Q47153253-49120ABC-5340-4215-BC70-0944470A09B1Q58710862-739BE637-2E0D-430A-9062-B5A3A10B3FCB
P2860
Endpoints for mouse abdominal tumor models: refinement of current criteria.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endpoints for mouse abdominal tumor models: refinement of current criteria.
@en
Endpoints for mouse abdominal tumor models: refinement of current criteria.
@nl
type
label
Endpoints for mouse abdominal tumor models: refinement of current criteria.
@en
Endpoints for mouse abdominal tumor models: refinement of current criteria.
@nl
prefLabel
Endpoints for mouse abdominal tumor models: refinement of current criteria.
@en
Endpoints for mouse abdominal tumor models: refinement of current criteria.
@nl
P2093
P2860
P1433
P1476
Endpoints for mouse abdominal tumor models: refinement of current criteria
@en
P2093
Debra L Hickman
Eden V Paster
Kimberly A Villines
P2860
P304
P577
2009-06-01T00:00:00Z